首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >Sequence‐Based In‐silico Discovery Characterisation and Biocatalytic Application of a Set of Imine Reductases
【2h】

Sequence‐Based In‐silico Discovery Characterisation and Biocatalytic Application of a Set of Imine Reductases

机译:一套亚胺还原酶的基于序列的硅化学发现表征和生物催化应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Imine reductases (IREDs) have recently become a primary focus of research in biocatalysis, complementing other classes of amine‐forming enzymes such as transaminases and amine dehydrogenases. Following in the footsteps of other research groups, we have established a set of IRED biocatalysts by sequence‐based in silico enzyme discovery. In this study, we present basic characterisation data for these novel IREDs and explore their activity and stereoselectivity using a panel of structurally diverse cyclic imines as substrates. Specific activities of >1 U/mg and excellent stereoselectivities (ee>99 %) were observed in many cases, and the enzymes proved surprisingly tolerant towards elevated substrate loadings. Co‐expression of the IREDs with an alcohol dehydrogenase for cofactor regeneration led to whole‐cell biocatalysts capable of efficiently reducing imines at 100 mM initial concentration with no need for the addition of extracellular nicotinamide cofactor. Preparative biotransformations on gram scale using these ‘designer cells’ afforded chiral amines in good yield and excellent optical purity.
机译:亚胺还原酶(IRED)最近成为生物催化研究的主要重点,补充了其他类型的成胺酶,例如转氨酶和胺脱氢酶。跟随其他研究小组的脚步,我们通过基于序列的计算机模拟酶发现建立了一组IRED生物催化剂。在这项研究中,我们介绍了这些新型IRED的基本表征数据,并使用一组结构多样的环状亚胺作为底物探索了它们的活性和立体选择性。在许多情况下,观察到的比活度> 1U / mg和出色的立体选择性(ee> 99%),并且这些酶令人惊讶地耐受较高的底物负载。 IREDs与醇脱氢酶的共表达可促进辅因子再生,从而导致全细胞生物催化剂能够以100 atmM的初始浓度有效还原亚胺,而无需添加细胞外烟酰胺辅因子。使用这些“设计细胞”进行克级的制备性生物转化,可获得高收率和优异的光学纯度的手性胺。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号